Lantheus Holdings (LNTH) Total Debt (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Total Debt of $570.4 million for Q1 2026, up 0.63% year-over-year from $566.8 million in Q1 2025, and little changed quarter-over-quarter from $569.4 million in Q4 2025.
Lantheus Holdings (LNTH) Total Debt (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Total Debt for 13 consecutive years, with $570.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Debt rose 0.63% year-over-year to $570.4 million; the TTM figure through Mar 2026 stood at $570.4 million (up 0.63% YoY), while the FY2025 annual figure was $569.4 million, up 0.56% from the prior year.
- Total Debt steadied at $570.4 million in Q1 2026 per LNTH's latest filing, from $569.4 million in the prior quarter.
- Across five years, Total Debt topped out at $657.4 million in Q4 2022 and bottomed at $167.4 million in Q3 2022.
- Historically, Total Debt has averaged $500.7 million across 5 years, with a median of $564.1 million in 2024.
- Annual changes were most pronounced in 2022 — Total Debt surged 276.17% — and 2023, when it declined 14.44%.
- Lantheus Holdings' Total Debt stood at $657.4 million in 2022, then slipped by 14.44% to $562.5 million in 2023, then gained by 0.67% to $566.3 million in 2024, then rose by 0.56% to $569.4 million in 2025, then advanced by 0.17% to $570.4 million in 2026.
- Business Quant data shows LNTH's Total Debt at $570.4 million in Q1 2026, $569.4 million in Q4 2025, and $568.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 760.00 Mn |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | 571.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 571.05 Mn |
| Mar 31, 2026 | 570.41 Mn |
| Dec 31, 2025 | 569.42 Mn |
| Sep 30, 2025 | 568.81 Mn |
| Jun 30, 2025 | 567.64 Mn |
| Mar 31, 2025 | 566.85 Mn |
| Dec 31, 2024 | 566.25 Mn |
| Sep 30, 2024 | 565.33 Mn |
| Jun 30, 2024 | 564.06 Mn |
| Mar 31, 2024 | 563.20 Mn |
| Dec 31, 2023 | 562.49 Mn |
| Sep 30, 2023 | 561.28 Mn |
| Jun 30, 2023 | 559.62 Mn |
| Mar 31, 2023 | 558.96 Mn |
| Dec 31, 2022 | 657.41 Mn |
| Sep 30, 2022 | 167.43 Mn |
| Jun 30, 2022 | 169.73 Mn |
| Mar 31, 2022 | 172.25 Mn |
| Dec 31, 2021 | 174.76 Mn |
| Sep 30, 2021 | 177.10 Mn |